Newsletter | June 25, 2024

06.25.24 -- Technology That Streamlines Sponsor And Site Collaboration

Using AI To Speed And Simplify Site Validation

Did you know AI can tap into data to create intelligent site profiles? Combining, comparing, and deriving insights from traditional, structured data and unstructured third-party data brings more context, nuance, and detail to the process, improving the accuracy of site selection.

 

How A Dedicated Medical Affairs Team Drives Site Engagement

Collaboration between sites, sponsors, CROs, and tech providers is crucial for patient delivery. Discover how recent enhancements to the Cognizant® Shared Investigator Platform (SIP) enable streamlined management and improved user experience.

 

Roche Cuts Feasibility Process By 36%

Uncover how an industry pioneer and veteran biotech benefited from Cognizant SIP, including streamlined feasibility questionnaires where principal investigators could spend more time addressing critical, study-specific topics and reduced overall completion time by 36%.

 

SOLUTIONS

AMR Shares How SIP Has Reduced Their Study Start Up Time

Missy MacPhail, Executive Director of Business Development at Alliance for Multispecialty Research, LLC, shares her positive experience with SIP, highlighting how it has benefited AMR.

• Request Information

 

 

 

TRG Clinical Site Director Discusses How SIP Provides The Possibility Of Increased Collaboration With Sponsors

In this testimonial, Clinical Site Director at Total Research Group, LLC, Kendaling Bruce, MHSA, describes her experience in efficiently streamlining collaboration with sponsors through the adept utilization of SIP.

• Request Information

 

 

 

CEO Of Pioneer Clinical Studies' Shares His SIP Testimonial

CEO and Site Director of Pioneer Clinical Studies Jeff Somerstein tells how Cognizant's Shared Investigator Platform (SIP) has increased his organization's visibility with sponsors.

• Request Information